This is notably lower than MT-1 (Afamelanotide), which has a molecular weight of 1,647.88 g/mol, reflecting the shorter chain length (7 vs 13 amino acids) and different structural architecture of the two compounds
Continuous glucose monitoring technology with and without insulin pump therapy is an emerging attractive approach to help insulin-treated people with DKD optimise their glycaemic control
And, of course, what this all means for incoming data, which is really important not just for investors but also for the Fed, as it kind of calibrate[s] their next move
Wegovy has been approved for use in medical weight-loss treatment plans for those who are considered obese (have a BMI of 30 or higher) or for those who are considered overweight and have at least one weight-related health condition (BMI of 27 or higher)
Use of semaglutide for this indication is supported by a 68-week, double-blind, placebo-controlled clinical trial in pediatric patients and from studies in adult patients with obesity
Implementation This is a novel study with potential implementation for weight management and obesity-related disorders
